Evolution Metals & Technologies Corp. (EM&T)
Evolution Metals & Technologies Corp. (EM&T) is a corporate name for which no verifiable brand evidence was supplied.
Last updated October 30, 2026
AI crawler reads
No AI crawler has read this profile yet.
Overview
Evolution Metals & Technologies Corp. (EM&T) is presented here only as a corporate name. The single piece of supplied evidence does not concern this entity at all: it is a press release about Debiopharm, a privately owned Swiss biopharmaceutical company, and its MultiLINK antibody-drug-conjugate linker technology presented at World ADC 2026 in San Diego. That document contains no mention of Evolution Metals & Technologies Corp., no products, no ownership details, no headquarters, no founding information and no market activity attributable to EM&T. Because the evidence is unrelated, this dossier cannot responsibly describe what EM&T sells, where it operates, who owns it, or when it was established. The name suggests a metals and technology orientation, but a name is not evidence, and no such claim is made here. No official website, Wikipedia entry or other reliable source was supplied for the company. This entry is therefore flagged for review. It should be revisited once genuine brand evidence — an official site, a corporate registry filing, a Wikipedia article or credible press coverage naming Evolution Metals & Technologies Corp. — becomes available. Until then, the record is intentionally minimal so that no invented facts enter the knowledge base.
Recent events
Evolution Metals & Technologies reaffirms FY2026 and FY2027 revenue guidance[2]
On October 14, 2026, Evolution Metals & Technologies Corp. (Nasdaq: EMAT), a U.S.-based critical materials and advanced manufacturing company, reaffirmed its fiscal 2026 revenue guidance of $10 million to $11 million and its fiscal 2027 revenue guidance of $400 million to $460 million.
EM&T plans to begin acquiring SmCo magnet production equipment by mid-2027[2]
On October 14, 2026, EM&T announced that it expects to begin acquiring equipment to produce samarium cobalt (SmCo) magnets, the magnet class relied upon across U.S. military systems, by mid-2027, with demand for compliant, non-China SmCo supply building as DFARS 252.225-7052 extends its restriction to SmCo magnets effective January 1, 2027.
EM&T unveils eight sintered NdFeB magnet grades with seven grades customer-certified[2]
On October 14, 2026, EM&T announced a portfolio of eight sintered neodymium-iron-boron (NdFeB) rare earth magnet grades — N42SH, N48SH, N46SH, N35SH, N45H, N42H, N48M and N50M — which the Company estimates represents approximately 75% of global sintered NdFeB magnet revenue. Seven of the eight grades have completed customer certification, led by N42SH, now in commercial production at EM&T's operations in Pohang, South Korea, while the eighth grade, N48SH, is in the final stages of customer certification.
EM&T advances Pohang capacity expansion as first ULVAC equipment containers arrive[2]
On October 14, 2026, EM&T reported that the first 13 of 57 containers of ULVAC sintered magnet production equipment have already arrived in Pohang, South Korea, with thirteen additional ULVAC machines being delivered; the expansion is expected to lift annual capacity to more than 10,000 metric tons, including approximately 6,000 metric tons of high-performance sintered magnets.
EM&T confirms it will respond to U.S. Army sources sought notice for rare earth magnets[2]
On October 14, 2026, EM&T confirmed it will respond to the sources sought notice issued by the U.S. Army Contracting Command, Aberdeen Proving Ground, Tobyhanna Division on September 28, 2026 to identify potential vendors of rare earth magnets, with responses due October 28, 2026, moving to supply the U.S. defense market.
Sources2 sources
Cite this profile: Cite the canonical profile. /brand-wiki/evolution-metals-and-technologies-corp-em-and-t · Editorial policy · How profiles are compiled